At IMCAS World 2026 in Paris, we met with plastic surgeon Dr. Carmelo Crisafulli at the CGBIO booth. As a global KOL for the CaHA biostimulator Facetem, he described the product as "one of the safest biostimulators on the market," highlighting what he described as a collagen-stimulating mechanism with a favorable inflammatory profile and the technological advantages of its proprietary Lattice-pore structure. He also noted the product's versatility across multiple treatment areas—including the face, neck, hands, and knees—and its adjustable dilution ratios, which allow practitioners to tailor applications from volume restoration to biostimulation. After visiting the Korean manufacturing facility firsthand, he shared that he was impressed by the quality standards and depth of supporting research data. His remarks reflect the broader global shift away from filler overinjection toward biostimulation, while also offering a firsthand view of how K-Medical Aesthetics is gaining recognition on the global stage.
#MedicalAestheticNews #IMCAS2026 #KMedicalAesthetics #CGBIO #DNCAesthetics #Facetem #DCLASSYCaHA #Biostimulator #DrCarmeloCrisafulli
"[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ㉖ | Interview with Dr. Carmelo Crisafulli, KOL for Facetem (DCLASSY CaHA)"
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11282

Comments
Post a Comment